Tabulated list of adverse reactions in Adult patients: See Table 1.
Tabulated list of adverse reactions in Pediatric patients: See Table 2.
Post-marketing data: Adverse events first identified as adverse reactions during post-marketing experience with Topiramate tablet are included in the table as follows. In each table, the frequencies are provided according to the following convention: Very common ≥1/10; Common ≥1/100 to <1/10; Uncommon ≥1/1,000 to <1/100; Rare ≥1/10,000 to <1/1,000; Very rare <1/10,000, including isolated reports.
Adverse Reactions Identified During Post-marketing Experience with Topiramate tablet by Frequency Category Estimated from Spontaneous Reporting Rates: See Table 3.
Sign Out